Tom Galassi | Investor Relations, LifeSci Advisors |
Chaim Lebovits | Chief Executive Officer |
Alla Patlis | Interim Chief Financial Officer |
Stacy Lindborg | Executive Vice President and Chief Development Officer |
Ralph Kern | President and Chief Medical Officer |
David Setboun | Executive Vice President and Chief Operating Officer |
David Bautz | Zacks Small-Cap Research |
Michelle Lorenz | Voices for ALS |
Greetings and welcome to the Brainstorm Cell Therapeutics First Quarter 2022 Conference Call. At this time, participants are in a listen-only mode.
As a reminder, this call is being recorded. And I would now like to introduce your host for today's conference, Tom Galassi of LifeSci Advisors. Mr.